Table 2.
(a) Anthropometric indices of female T2DM patients and controls. (b) Biochemical parameters of female T2DM patients and controls.
| (a) | ||||||
| Group A | Group B | Group C | Group D | Controls | ||
| Number | 11 | 10 | 11 | 9 | 41 | |
| Parameter | ||||||
| Age | 45 (27–56) | 48 (29–55) | 47 (31–65) | 48 (29–64) | 48 (27–64) | |
| WHR | 0.94 (0.84–1.03) | 0.95 (0.82–1.02) | 1.05 (0.98–1.12) ** N | 1.08 (1.01–1.16) * M | 0.85 (0.78–0.96) | |
| BMI (kg/m2) | 21.32 ± 2.18 | 28.42 ± 2.32 | 33.98 ± 3.22 * N | 47.22 ± 4.88 * XY | 21.2 ± 1.66 | |
| (b) | ||||||
| Group A | Group B | Group C | Group D | Controls | ||
| Number | 11 | 10 | 11 | 9 | 41 | |
| Parameter | ||||||
| Fasting glucose(mg/dL) | 117 (92–131) | 111 (87–129) | 112 (92–139) | 121 (97–152) | 96 (82–114) | |
| HbA1c (g/dL) | 7.9 ± 1.14 * | 8.1 ± 1.08 * | 8.2 ± 1.38 * M | 8.1 ± 0.89 * | 4.5 ± 0.43 | |
| Cholesterol-T | 198 (149–229) | 208 (145–240) | 216 (156–232) | 223 (161–253) | 168 (132–224) | |
| HDL-C(mg/dL) | 52 (41–63) | 50 (40–60) | 44 (33–61) | 42 (31–57) | 56 (41–66) | |
| LDL-C(mg/dL) | 88 ± 26.34 | 108 ± 32.12 | 103 ± 29.28 | 121 ± 28.18 | 96 ± 28.22 | |
| TG (mg/dL) | 120 (98–172) | 138 (90–218) | 146 (102–225) | 186 (101–238) | 96 (88–124) | |
For Part (a): WHR—waist-to-hip ratio; BMI—body mass index. Group A—T2DM patients with normal body weight; group B–overweight T2DM patients; group C—T2DM patients with obesity; and group D —T2DM patients with severe obesity. * p < 0.001 vs. control group; ** p < 0.01 vs. control group; M p < 0.001 vs. groups A and B, N p < 0.01 vs. groups A and B; X p < 0.001 vs. group A; Y p < 0.01 vs. group C. For Part (b): HbA1c—glycated hemoglobin; Cholesterol-T—total cholesterol; HDL—high-density lipoprotein; LDL—low-density lipoprotein; TG—triglycerides. Group A—T2DM patients with normal body weight; group B—overweight T2DM patients; group C—T2DM patients with obesity; and group D —T2DM patients with severe obesity. * p < 0.001 vs. control group; M p < 0.001 vs. group A and B.